"50242-933-86" National Drug Code (NDC)

NDC Code	50242-933-86
Package Description	1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE
Product NDC	50242-933
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Tecentriq Hybreza
Non-Proprietary Name	Atezolizumab And Hyaluronidase-tqjs
Dosage Form	INJECTION
Usage	SUBCUTANEOUS
Start Marketing Date	20240912
Marketing Category Name	BLA
Application Number	BLA761347
Manufacturer	Genentech, Inc.
Substance Name	ATEZOLIZUMAB; HYALURONIDASE (HUMAN RECOMBINANT)
Strength	1875; 30000
Strength Unit	mg/15mL; U/15mL
Pharmacy Classes	Antibodies [CS], Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]